Swiss Roche, in the wake of Trump's tariff policy, will invest $ 50 billion in the US

The Swiss pharmaceutical company Roche has said it will invest $ 50 billion in the US over the next five years. Reuters writes about it. This decision has become part of the wave of large investments of international pharmaceutical companies in the United States in the wake of Donald Trump's administration policy, which has new rates ...